-
Loading metrics
An Integrated Disease/Pharmacokinetic/Pharmacodynamic Model Suggests Improved Interleukin-21 Regimens Validated Prospectively for Mouse Solid Cancers
- Moran Elishmereni,
- Yuri Kheifetz,
- Henrik Søndergaard,
- Rune Viig Overgaard,
- Zvia Agur
x
- Published: September 29, 2011
- https://doi.org/10.1371/journal.pcbi.1002206